Free radicals are highly reactive chemical species generated during normal
metabolic processes, which in excess can lead to membrane damage. Elaborate
antioxidant defence systems exist to protect against oxidative stress. The
re is accumulating evidence of altered antioxidant capacity in schizophreni
a. Membrane dysfunction can be secondary to free radical-mediated pathology
. and may contribute to specific aspects of schizophrenic symptomatology an
d complications of its treatment. Specifically. free radical-mediated abnor
malities may contribute to the development of a number of clinically signif
icant consequences, including prominent negative symptoms, tardive dyskines
ia, neurological 'soft' signs and parkinsonian symptoms. Our previous resul
ts showing altered membrane dynamics and antioxidant enzyme activities in s
chizophrenia, and findings from other investigators, are consistent with th
e notion of free radical-mediated neurotoxicity in schizophrenia. These fin
dings provide a theoretical basis from which the development of novel thera
peutic strategies such as fatty acid and antioxidant supplementation can oc
cur in the future.